Politics · India Bureau
Gujarat Cracks Down on Pharma Firms, Cancels 50 Licenses
Gujarat's drug regulator has cancelled licenses for 50 pharmaceutical companies and ordered the closure of two manufacturing units as part of a stringent crackdown on counterfeit medicines. Health Minister Praful Pansheriya confirmed the enforcement action reflects the state's zero-tolerance approach toward spurious drugs.
LSN India ·
The Gujarat Food and Drug Control Administration (FDCA) has intensified its regulatory oversight by revoking licenses of 50 drug manufacturing firms operating within the state, officials said. The action marks a significant enforcement push against pharmaceutical companies failing to meet quality and safety standards.
In addition to the license cancellations, the FDCA has ordered the immediate closure of two manufacturing units as part of the broader initiative. Health Minister Praful Pansheriya underscored that the state maintains an uncompromising stance on counterfeit and substandard medicines, which pose serious public health risks.
The crackdown reflects growing regulatory attention to pharmaceutical compliance across India's drug manufacturing sector. Gujarat, home to a substantial portion of India's pharmaceutical industry, has increasingly tightened inspections and enforcement mechanisms to safeguard consumer health and maintain industry integrity.
Officials did not immediately provide details regarding the specific violations cited against the 50 firms or timelines for the closure of the two units. The regulatory action underscores state authorities' commitment to ensuring that only licensed, compliant manufacturers operate within Gujarat's pharmaceutical market.